Baxter Hits 52-Week High on Planned Business Split-Up
Baxter International Inc. ( BAX ) revealed that it will split-up its biopharmaceuticals and medical device segments into two independent companies in order to put greater management focus on the two businesses, effectively commercialize product offerings, efficiently allocate resources to high growth areas, and bring flexibility in deciding on growth and investment strategies. Following the announcement, shares of BAX reached new 52-week high of $75.68 to close at $72.80 on the same day […]